Researchers at Montefiore-Einstein Heart Center Receive Prestigious New NIH Award for Pioneering Studies in Cardiothoracic Surgery

July 20, 2007 - (BRONX, NY) - Researchers at the Albert Einstein College of Medicine of Yeshiva University and the Montefiore-Einstein Heart Center have received a five-year $2 million grant from the National Institutes of Health (NIH) to conduct pioneering studies in cardiovascular disease management. Robert E. Michler, M.D., the principal investigator for the grant, is professor and chairman of cardiothoracic surgery at Einstein and Montefiore, co-director of the Montefiore-Einstein Heart Center, and the Samuel I. Belkin Professor at Einstein.

Elizabeth G. Nabel, M.D., Director of the National Heart, Lung, and Blood Institute of the National Institutes of Health commented, "By enhancing the ability of research teams to evaluate new techniques, technologies, and devices, the Network promises to improve the scientific basis of care in cardiovascular disease."

"This five-year NIH Network grant has the potential to dramatically improve the treatment of cardiovascular disease, still the leading cause of death in the United States and Canada," said Allen M. Spiegel, M.D., The Marilyn and Stanley M. Katz Dean at Einstein. "We are gratified to be a part of this award and these important studies."

The seven participating institutions will collaborate closely during the five-year research period to improve technologies used in treating cardiovascular disease, and will meet regularly throughout the year to exchange data and compare findings. "Our participation in this innovative collaboration among leading U.S. and Canadian heart centers, places the Montefiore-Einstein Heart Center at the forefront of cutting-edge cardiovascular research. It is our hope and expectation that this study will lead to significant improvements in cardiovascular disease outcomes for patients," said Dr. Michler.

Additional researchers from Albert Einstein College of Medicine and the Montefiore-Einstein Heart Center who will participate in the study include:
Daniel Goldstein, M.D.; David D'Alessandro, M.D.; Ricardo Bello, M.D./Ph.D.; Simon Maybaum, M.D.; V.S. Srinivas, M.D.; Roger Swayze, R.N.; Hillel Cohen, Ph.D.; Richard Kitsis, M.D.; Linda Haramati, M.D.; and Daniel Spevak, M.D.

Only seven heart centers in the United States and Canada were selected to participate in this landmark study of evidence-based medicine in cardiothoracic surgical practice. The others are: the Cleveland Clinic; Duke Medical Center, the University of Virginia; Emory and Columbia Universities; and the Montreal Heart Institute.